Symrise Cosmetic Ingredients has entered into a strategic partnership with German enzymes and probiotics specialist Evoxx Technologies.
Under the partnership, Symrise will work with the biotech company to co-develop processes and ingredients for all customers that aim to integrate clean and sustainable alternatives into their cosmetic formulas.
The partners intend to develop biotechnological processes for ingredients used in beauty applications.
Evoxx, based in Monheim am Rhein, will contribute its expertise in research and development as well as its global leadership in manufacturing of enzymes and probiotics. Symrise adds their knowledge and capabilities in creating innovative and sustainable cosmetic ingredients.
As a result, consumers will receive beauty products addressing their wishes for effective and responsible ingredients.
“The partnership with Evoxx Technologies represents a significant step towards further developing our biotech platform. It helps accomplish our strategic goal to continuously expand our portfolio of sustainable cosmetic ingredients”, said Dr. Jörn Andreas, President Cosmetic Ingredients at Symrise.
Evoxx managing director Dr Michael Puls added: “By uniting our competencies, we will jointly advance natural, and green solutions. It will accelerate the ability to address the desires of customers and consumers for high performing and yet sustainable products.”
In a related development, Symrise is presenting its augmented AI Philyra at the World Perfumery Congress (WPC) in Miami this week.
Together with IBM Research, Symrise has been working on the evolution of its cognitive creativity based on artificial intelligence in perfumery over the past few years.
Philyra 2.0 enables the targeted use of environmentally friendly and renewable raw materials, which perfumers can use to create innovative fragrance creations.